These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38728098)

  • 21. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal keratitis caused by Fusarium solani.
    Mahmoud YA
    Mycoses; 2007 Jan; 50(1):64-70. PubMed ID: 17302751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual delivery systems combining nanocrystals and dissolving microneedles for improved local vaginal delivery of fluconazole.
    Aziz AYR; Mahfufah U; Syahirah NA; Habibie ; Asri RM; Yulianty R; Kastian RF; Sari YW; Chabib L; Hamzah H; Permana AD
    Drug Deliv Transl Res; 2024 Jun; 14(6):1678-1692. PubMed ID: 38036850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
    El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
    Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scedosporium apiospermum keratitis treated with itraconazole.
    Saracli MA; Erdem U; Gonlum A; Yildiran ST
    Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of a prenylated flavonoid from Dalea elegans with fluconazole against azole- resistant Candida albicans.
    Barceló S; Peralta M; Calise M; Finck S; Ortega G; Diez RA; Cabrera JL; Pérez C
    Phytomedicine; 2017 Aug; 32():24-29. PubMed ID: 28732804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanocubosomal based
    Hosny KM; Rizg WY; Alkhalidi HM; Abualsunun WA; Bakhaidar RB; Almehmady AM; Alghaith AF; Alshehri S; El Sisi AM
    Drug Deliv; 2021 Dec; 28(1):1836-1848. PubMed ID: 34515597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis.
    Mahdy RA; Nada WM; Wageh MM; Kader MA; Saleh MM; Alswad MM
    Cutan Ocul Toxicol; 2010 Sep; 29(3):193-7. PubMed ID: 20462395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing Susceptibility of Drug-Resistant
    Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dual-functional chitosan derivative platform for fungal keratitis.
    Shi L; Li Z; Liang Z; Zhang J; Liu R; Chu D; Han L; Zhu L; Shen J; Li J
    Carbohydr Polym; 2022 Jan; 275():118762. PubMed ID: 34742450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
    Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
    Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
    Mahdy RA; Nada WM; Wageh MM
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies.
    Durgun ME; Kahraman E; Hacıoğlu M; Güngör S; Özsoy Y
    Drug Deliv Transl Res; 2022 Mar; 12(3):662-675. PubMed ID: 33830458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.
    Rençber S; Karavana SY; Yılmaz FF; Eraç B; Nenni M; Özbal S; Pekçetin Ç; Gurer-Orhan H; Hoşgör-Limoncu M; Güneri P; Ertan G
    Int J Nanomedicine; 2016; 11():2641-53. PubMed ID: 27358561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans.
    Hunsaker EW; McAuliffe KJ; Franz KJ
    J Biol Inorg Chem; 2020 Aug; 25(5):729-745. PubMed ID: 32542530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluconazole in filamentous fungal keratitis.
    Rao SK; Madhavan HN; Rao G; Padmanabhan P
    Cornea; 1997 Nov; 16(6):700. PubMed ID: 9395885
    [No Abstract]   [Full Text] [Related]  

  • 39. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole.
    Bezerra CF; de Alencar Júnior JG; de Lima Honorato R; Dos Santos ATL; Pereira da Silva JC; Gusmão da Silva T; Leal ALAB; Rocha JE; de Freitas TS; Tavares Vieira TA; Bezerra MCF; Sales DL; Kerntopf MR; de Araujo Delmondes G; Filho JMB; Peixoto LR; Pinheiro AP; Ribeiro-Filho J; Coutinho HDM; Morais-Braga MFB; Gonçalves da Silva T
    Chem Phys Lipids; 2020 Nov; 233():104987. PubMed ID: 33058818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.
    Nasr M; Teiama M; Ismail A; Ebada A; Saber S
    Drug Deliv Transl Res; 2020 Dec; 10(6):1841-1852. PubMed ID: 32779112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.